CannaPharmaRX, Inc. CPMD OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

22/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

CannaPharmaRX, Inc. (CPMD) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 20/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

22/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

25/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

15/100

→ Income

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — CPMD

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio1.85

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-0.02

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2016	$-0.06	$0.00	$-1M	-
2017	$0.00	$0.00	$-6.63K	-
2018	$-0.17	$0.00	$-3.09M	-
2019	$-0.66	$0.00	$-20.45M	-
2020	$-0.49	$0.00	$-19.89M	-
2021	$-0.12	$0.00	$-8.83M	-
2022	$-0.04	$0.00	$-8.53M	-
2023	$0.01	$0.00	$3.69M	-
2024	$-0.02	$820.14K	$-9.91M	-1207.8%
2025	$-0.02	$1.36M	$-11.13M	-817.2%